Purine antagonists for chronic lymphocytic leukaemia.

Steurer M, Pall G, Richards S, Schwarzer G, Bohlius J, Greil R. Cochrane Database Syst Rev. 2006 Jul 19,(3):CD004270.

Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years‘ adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.

Jakesz R, Jonat W, Gnant M, Mittlboeck M, Greil R, Tausch C, Hilfrich J, Kwasny W, Menzel C, Samonigg H, Seifert M, Gademann G, Kaufmann M, Wolfgang J Lancet. 2005 Aug 6-12,366(9484):455-62.

Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin’s lymphoma: final results of the German Hodgkin’s Lymphoma Study Group Trial HD5.

Sieber M, Tesch H, Pfistner B, Rueffer U, Lathan B, Brosteanu O, Paulus U, Koch T, Pfreundschuh M, Loeffler M, Engert A, Josting A, Wolf J, Hasenclever D, Franklin J, Duehmke E, Georgii A, Schalk KP, Kirchner H, Doelken G, Munker R, Koch P, et al. J Clin Oncol. 2002 Jan 15,20(2):476-84.

Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin’s lymphoma: a single-institution study.

Krugmann J, Tzankov A, Gschwendtner A, Fischhofer M, Greil R, Fend F, Dirnhofer S. Mod Pathol. 2003 Jun,16(6):566-73.

Tracking death dealing by Fas and TRAIL in lymphatic neoplastic disorders: pathways, targets and therapeutic tools.

Greil R, Anether G, Johrer K, Tinhofer I. J Leukoc Biol. 2003 Sep,74(3):311-30.

Treatment of advanced Hodgkin’s disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin’s Lymphoma Study Group HD6 trial.

Sieber M, Tesch H, Pfistner B, Rueffer U, Paulus U, Munker R, Hermann R, Doelken G, Koch P, Oertel J, Roller S, Worst P, Bischof H, Glunz A, Greil R, von Kalle K, Schalk KP, Hasenclever D, Brosteanu O, Duehmke E, Georgii A, Engert A, et al. Ann Oncol. 2004 Feb,15(2):276-82.

Transendothelial migration of myeloma cells is increased by tumor necrosis factor (TNF)-alpha via TNF receptor 2 and autocrine up-regulation of MCP-1.

Jöhrer K, Janke K, Krugmann J, Fiegl M, Greil R. Clin Cancer Res. 2004 Mar 15,10(6):1901-10.

Unfavourable prognosis of patients with trisomy 18q21 detected by fluorescence in situ hybridisation in t(11,18) negative, surgically resected gastrointestinal B cell lymphomas.

Krugmann J, Tzankov A, Dirnhofer S, Fend F, Greil R, Siebert R, Erdel M. J Clin Pathol. 2004 Apr,57(4):360-4.

Is higher income and educational status associated with poorer outcome in patients with Hodgkin’s disease?

Holzner B, Fischhofer M, Kemmler G, Kopp M, Sperner-Unterweger B, Krugmann J, Dirnhofer S, Greil R. Eur J Haematol. 2004 Nov,73(5):318-24.

Prognostic significance of CD20 expression in classical Hodgkin lymphoma: a clinicopathological study of 119 cases.

Tzankov A, Krugmann J, Fend F, Fischhofer M, Greil R, Dirnhofer S. Clin Cancer Res. 2003 Apr,9(4):1381-6.